Recurrent UTI: beyond infection — the ecological puzzle
This narrative review reframes recurrent UTI as a multifactorial ecological phenomenon — involving microbiota, host immunity, and interconnected bacterial reservoirs — but provides no primary effect estimates to support definitive therapeutic conclusions.
| Population | Patients with recurrent UTI (≥2 episodes in 6 months or ≥3 in 12 months), all ages and sexes |
|---|---|
| Intervention | Ecological and multi-omic models of pathogenesis (urinary microbiota, bacterial reservoirs, host immunity, hormonal factors) |
| Comparator | Classic model of independent recurrent infection diagnosed by standard urine culture |
| Outcome | Recurrence rate by same bacterial strain; Microbial detection by expanded methods vs. standard urine culture; Impact of intracellular reservoirs on bacterial persistence; Global burden and mortality associated with UTI; Terminological inconsistency and impact on diagnosis and treatment; Role of urogenital and intestinal microbiota in recurrence; Emerging therapeutic strategies (probiotics, bacteriophages, vaccines) |
Summary of findings
| Outcome | Effect | 95% CI | Certainty | Clinical relevance | Notes |
|---|---|---|---|---|---|
| Recurrence rate by same bacterial strain | ~50% of recurrent episodes caused by same strain; in the 95% CI reported | — | Low | — | |
| Microbial detection by expanded methods vs. standard urine culture | narrative synthesis only; in the quantitative effect measure reported | — | Low | — | |
| Impact of intracellular reservoirs on bacterial persistence | narrative synthesis only; in the quantitative effect measure reported | — | Low | — | |
| Global burden and mortality associated with UTI | >405 million cases/year; ~240,000 deaths/year; in the CI reported | — | Low | — | 1 studies |
| Terminological inconsistency and impact on diagnosis and treatment | narrative synthesis only; in the quantitative effect measure reported | — | Very low | — | |
| Role of urogenital and intestinal microbiota in recurrence | narrative synthesis only; in the quantitative effect measure reported | — | Low | — | |
| Emerging therapeutic strategies (probiotics, bacteriophages, vaccines) | narrative synthesis only; in the quantitative effect measure reported | — | Very low | — |
Context
UTIs affect more than 405 million people per year and cause approximately 240,000 deaths annually; recurrences impose substantial clinical burden through repeated antibiotic exposure and quality-of-life impairment. The predominant clinical definition relies on temporal frequency of episodes, but growing evidence indicates this criterion poorly captures the underlying biological heterogeneity. Conventional diagnostic methods (standard urine culture) underdetect low-biomass communities, intracellular reservoirs, and fastidious organisms.
What the study showed
The review synthesizes evidence that approximately 50% of recurrent episodes are caused by the same bacterial strain as the initial infection, suggesting persistence in host reservoirs (bladder, intestine, vagina, periurethral region, prostate) rather than independent reinfection. Expanded methods (expanded quantitative urine culture, metagenomics, metabolomics) reveal greater microbial complexity than standard urine culture detects. No primary data with confidence intervals or effect sizes are presented; all findings are syntheses of secondary literature.
How it was done
Narrative review (non-systematic); no registered protocol, no declared systematic search, no formal risk-of-bias assessment of included studies. Integrates microbiological, immunological, and multi-omic studies from diverse populations and designs. No own sample size or follow-up duration.
Effect magnitude
No effect estimates (RR, OR, SMD, MD) are directly reported by this review. The only quantitative figure cited is ~50% of recurrences caused by the same strain, without a 95% CI provided by the source study.
Risk of bias
Narrative review without prospective registration, explicit eligibility criteria, or risk-of-bias assessment (AMSTAR-2 not formally applicable; no ROBINS-I or equivalent tool applied to included studies). Study selection potentially biased by authorial curation. Heterogeneity of populations and methodologies in cited studies precludes quantitative synthesis. Disproportionate representation of female and high-income country populations in underlying studies.
What this study does NOT prove
This review does not prove causality between any ecological factor and UTI recurrence, nor does it support specific therapeutic recommendations. It is not generalizable to pediatric populations, severely immunocompromised patients, or low-income settings without additional evidence.
In clinical practice
Clinicians should recognize that a negative standard urine culture does not exclude microbiologically active disease in symptomatic recurrent UTI patients. Clinical terminology (recurrence vs. relapse vs. persistence) should be applied with awareness of its biological limitations. Expanded diagnostic strategies and assessment of reservoirs (intestinal, vaginal, intravesical) may be considered in refractory cases, although evidence for routine application remains insufficient.
Limitations
Narrative review without prospective registration, explicit eligibility criteria, or risk-of-bias assessment (AMSTAR-2 not formally applicable; no ROBINS-I or equivalent tool applied to included studies). Study selection potentially biased by authorial curation. Heterogeneity of populations and methodologies in cited studies precludes quantitative synthesis. Disproportionate representation of female and high-income country populations in underlying studies.
What is still missing
Randomized controlled trials testing interventions targeting specific reservoirs (intracellular, intestinal) using standardized outcomes based on advanced microbiology rather than symptom criteria alone.
Technical appendix
Version history
- 1.0 · 2026-10-24 — Auto-generated under Evidence Standard v1.0